A restricted signature of miRNAs distinguishes APL blasts from normal promyelocytes

Oncogene

Volumn 28, Issue 45, 2009, Pages 4034-4040

  Careccia, S ^a   Mainardi, S ^a,g   Pelosi, A ^a   Gurtner, A ^a   Diverio, D ^b   Riccioni, R ^c   Testa, U ^c   Pelosi, E ^c   Piaggio, G ^a   Sacchi, A ^a   Lavorgna, S ^d,e   Lo Coco, F ^d,e   Blandino, G ^a,f   Levrero, M ^b,f   Rizzo, M G ^a  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^d UNIVERSITY OF ROME TOR VERGATA   (Italy)

^e IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^f Rome Oncogenomic Center   (Italy)

^g Centro Nacional de Investigaciones Oncológicas   (Spain)

Author keywords

Acute promyelocytic leukemia; MicroRNAs; PML RARa

Indexed keywords

HISTONE H3; MICRORNA; RETINOIC ACID; RETINOIC ACID RECEPTOR ALPHA;

ARTICLE; BLAST CELL; CELL DIFFERENTIATION; CELL LINEAGE; CHROMATIN IMMUNOPRECIPITATION; GRANULOCYTE; HUMAN; OPEN READING FRAME; PRIORITY JOURNAL; PROMYELOCYTE; PROMYELOCYTIC LEUKEMIA; PROTEIN MODIFICATION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION INITIATION;

GRANULOCYTE PRECURSOR CELLS; HUMANS; LEUKEMIA, PROMYELOCYTIC, ACUTE; MICRORNAS;

EID: 70449628970     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2009.255     Document Type: Article

References (26)

1. Abramovich C, Humphries RK. (2005). Hox regulation of normal and leukemic hematopoietic stem cells. Curr Opin Hematol 12: 210-216.
2. Bartel DP. (2004). MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
3. Chen CZ, Li L, Lodish HF, Bartel DP. (2004). MicroRNAs modulate hematopoietic lineage differentiation. Science 303: 83-86.
4. De Marchis ML, Ballarino M, Salvatori B, Puzzolo MC, Bozzoni I, Fatica A. (2009). A new molecular network comprising PU.1, interferon regulatory factor proteins and miR-342 stimulates ATRA-mediated granulocytic differentiation of acute promyelo-cytic leukemia cells. Leukemia 23: 856-862.
5. Diaz-Blanco E, Bruns I, Neumann F, Fischer JC, Graef T, Rosskopf M et al. (2007). Molecular signature of CD34(+) hematopoietic stem and progenitor cells of patients with CML in chronic phase. Leukemia 21: 494-504.
6. Fabbri M, Garzon R, Andreeff M, Kantarjian HM, Garcia-Manero G, Calin GA. (2008). MicroRNAs and noncoding RNAs in hematological malignancies: molecular, clinical and therapeutic implications. Leukemia 22: 1095-1105.
7. Fazi F, Rosa A, Fatica A, Gelmetti V, De Marchis ML, Nervi C et al. (2005). A minicircuitry comprised of microRNA-223 and transcription factors NFI-A and C/EBPalpha regulates human granulo-poiesis. Cell 123: 819-831.
8. Fontana L, Pelosi E, Greco P, Racanicchi S, Testa U, Liuzzi F et al. (2007). MicroRNAs 17-5p-20a-106a control monocytopoiesis through AML1 targeting and M-CSF receptor upregulation. Nat Cell Biol 9: 775-787.
9. Garzon R, Pichiorri F, Palumbo T, Visentini M, Aqeilan R, Cimmino A et al. (2007). MicroRNA gene expression during retinoic acid-induced differentiation of human acute promyelocytic leukemia. Oncogene 26: 4148-4157.
10. Grady WM, Parkin RK, Mitchell PS, Lee JH, Kim Y-H, Tsuchiya KD et al. (2008). Epigenetic silencing of the intronic microRNA hsa-miR-342 and its host gene EVL in colorectal cancer. Oncogene 27: 3880-3888.
11. Grignani F, Ferrucci PF, Testa U, Talamo G, Fagioli M, Alcalay M et al. (1993). The acute promyelocytic leukemia-specific PML-RAR alpha fusion protein inhibits differentiation and promotes survival of myeloid precursor cells. Cell 74: 423-431.
12. Johnson SM, Grosshans H, Shingara J, Byrom M, Jarvis R, Cheng A et al. (2005). RAS is regulated by the let-7 microRNA family. Cell 120: 635-647.
13. Kim YK, Kim VN. (2007). Processing of intronic microRNAs. EMBO J 26: 775-783.
14. Kumar AR, Quanzhi L, Hudson WA, Chen W, Sam T, Yao Q et al. (2009). A role for MEIS1 in MLL-fusion gene leukemia. Blood 113: 1756-1758.
15. Mainardi S, Pelosi A, Palescandolo E, Riccioni R, Fontemaggi G, Diverio D et al. (2007). DeltaN-p73 is a transcriptional target of the PML/RARalpha oncogene in myeloid differentiation. Cell Death Diff 14: 1968-1971.
16. Mallardo M, Poltronieri P, D'Urso OF. (2008). Non-protein coding RNA biomarkers and differential expression in cancers: a review. J Exp Clin Cancer Res 27: 19.
17. Mandelli F, Diverio D, Avvisati G, Luciano A, Barbui T, Bernasconi C et al. (1997). Molecular remission in PML/RAR alpha-positive acute promyelocytic leukemia by combined all-trans retinoic acid and idarubicin (AIDA) therapy. Gruppo Italiano-Malattie Ematologiche Maligne dell'Adulto and Associazione Italiana di Ematologia ed Oncologia Pediatrica Cooperative Groups. Blood 90: 1014-1021.
18. Melnick A, Licht JD. (1999). Deconstructing a disease: RARalpha, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia. Blood 93: 3167-3215.
19. Meltzer PS. (2005). Cancer genomics: small RNAs with big impacts. Nature 435: 745-746.
20. Pasquinelli AE, Hunter S, Bracht J. (2005). MicroRNAs: a developing story. Curr Opin Genet Dev 15: 200-205.
21. Peng Y, Laser J, Shi G, Mittal K, Melamed J, Lee P et al. (2008). Antiproliferative effects by Let-7 repression of high-mobility group A2 in uterine leiomyoma. Mol Cancer Res 6: 663-673.
22. Rodriguez A, Griffiths-Jones S, Ashurst JL, Bradley A. (2004). Identification of mammalian microRNA host genes and transcription units. Genome Res 14: 1902-1910.
23. Rosenauer A, Raelson JV, Nervi C, Eydoux P, DeBlasio A, Miller WH. (1996). Alterations in expression, binding to ligand and DNA, and transcriptional activity of rearranged and wild-type retinoid receptors in retinoid-resistant acute promyelocytic leukaemia cell lines. Blood 88: 2671-2682.
24. Saumet A, Vetter G, Bouttier B, Casamar-Portales E, Wasserman WW, Maurin T et al. (2009). Transcriptional repression of microRNA genes by PML-RARA increases expression of key cancer proteins in acute promyelocytic leukemia. Blood 113: 412-421.
25. Tallman MS, Nabhan C, Feusner JH, Rowe JM. (2002). Acute promyelocytic leukemia: evolving therapeutic strategies. Blood 99: 759-767.
26. Testa U, Fossati C, Samoggia P, Masciulli R, Mariani G, Hassan HJ et al. (1996). Expression of growth factor receptors in unilineage differentiation culture of purified hematopoietic progenitors. Blood 88: 3391-3406 (Pubitemid 26365573)